RPRX - Company ID 0001802768
Royalty Pharma plc has filed 588 public company documents between 2020 and 2026. The most frequent type is insider trade (283 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 4 | Insider trade | 11mo ago2025-07-31 | 2025-07-31 | View filing |
| 4 | Insider trade | 11mo ago2025-07-31 | 2025-07-31 | View filing |
| 3 | New insider ownership | 11mo ago2025-07-25 | 2025-07-17 | View filing |
| 3 | New insider ownership | 11mo ago2025-07-25 | 2025-07-17 | View filing |
| 8-K | Major company event | 11mo ago2025-07-17 | 2025-07-17 | View filing |
| 4 | Insider trade | 1y ago2025-06-30 | 2025-06-30 | View filing |
| 4 | Insider trade | 1y ago2025-06-30 | 2025-06-30 | View filing |
| SCHEDULE 13D | SCHEDULE 13D | 1y ago2025-05-23 | - | View filing |
| 4 | Insider trade | 1y ago2025-05-20 | 2025-05-16 | View filing |
| 4 | Insider trade | 1y ago2025-05-20 | 2025-05-16 | View filing |
| 4 | Insider trade | 1y ago2025-05-20 | 2025-05-16 | View filing |
| 4 | Insider trade | 1y ago2025-05-20 | 2025-05-16 | View filing |
| 4 | Insider trade | 1y ago2025-05-20 | 2025-05-16 | View filing |
| 8-K | Major company event | 1y ago2025-05-19 | 2025-05-16 | View filing |
| S-8 | Employee stock plan | 1y ago2025-05-16 | - | View filing |
| 4 | Insider trade | 1y ago2025-05-15 | 2025-05-13 | View filing |
| 4 | Insider trade | 1y ago2025-05-14 | 2025-05-13 | View filing |
| 4 | Insider trade | 1y ago2025-05-14 | 2025-05-13 | View filing |
| 4 | Insider trade | 1y ago2025-05-14 | 2025-05-13 | View filing |
| 4 | Insider trade | 1y ago2025-05-14 | 2025-05-13 | View filing |
| 4 | Insider trade | 1y ago2025-05-14 | 2025-05-13 | View filing |
| 4 | Insider trade | 1y ago2025-05-14 | 2025-05-13 | View filing |
| 4 | Insider trade | 1y ago2025-05-14 | 2025-05-13 | View filing |
| 4 | Insider trade | 1y ago2025-05-14 | 2025-05-12 | View filing |
| 8-K | Major company event | 1y ago2025-05-12 | 2025-05-12 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-12 | - | View filing |
| 4 | Insider trade | 1y ago2025-05-09 | 2025-05-08 | View filing |
| 4 | Insider trade | 1y ago2025-05-09 | 2025-05-08 | View filing |
| 4 | Insider trade | 1y ago2025-05-09 | 2025-05-08 | View filing |
| 4 | Insider trade | 1y ago2025-05-09 | 2025-05-08 | View filing |
| 4 | Insider trade | 1y ago2025-05-09 | 2025-05-08 | View filing |
| 10-Q | Quarterly report | 1y ago2025-05-08 | 2025-03-31 | View filing |
| 8-K | Major company event | 1y ago2025-05-08 | 2025-05-08 | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 1y ago2025-05-02 | - | View filing |
| 4 | Insider trade | 1y ago2025-04-21 | 2025-04-21 | View filing |
| 3/A | 3/A | 1y ago2025-04-21 | 2025-04-07 | View filing |
| 3 | New insider ownership | 1y ago2025-04-21 | 2025-04-07 | View filing |
| DEFA14A | Proxy materials | 1y ago2025-04-11 | - | View filing |
| 8-K | Major company event | 1y ago2025-04-11 | 2025-04-11 | View filing |
| ARS | Annual report to shareholders | 1y ago2025-04-11 | 2024-12-31 | View filing |
| DEFM14A | DEFM14A | 1y ago2025-04-11 | - | View filing |
| DEFA14A | Proxy materials | 1y ago2025-04-10 | - | View filing |
| 8-K | Major company event | 1y ago2025-04-10 | 2025-04-07 | View filing |
| UPLOAD | SEC correspondence | 1y ago2025-04-09 | - | View filing |
| CORRESP | Company correspondence | 1y ago2025-04-04 | - | View filing |
| 4 | Insider trade | 1y ago2025-04-01 | 2025-03-31 | View filing |
| 4 | Insider trade | 1y ago2025-04-01 | 2025-03-31 | View filing |
| UPLOAD | SEC correspondence | 1y ago2025-03-28 | - | View filing |
| DEFA14A | Proxy materials | 1y ago2025-03-05 | - | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 1y ago2025-02-21 | - | View filing |